Published in Lab Business Week, May 13th, 2007
Zolpidem Tartrate is a sedative-hypnotic drug, which is indicated for the short-term treatment of insomnia characterized by difficulties with sleep initiation. This new product is the bioequivalent to Ambien(R), a registered trademark of Sanofi-aventis. Ambien(R) had U.S. sales of approximately $2.09 billion for the 12-month period ended Dec. 31, 2006, according to IMS Data. Caraco has two strengths available, 5 mg and 10 mg tablets.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.